Fosun International LTD Cerus Corp Transaction History

Fosun International LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$4.86 - $6.05 $3.25 Million - $4.05 Million	-669,245 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$4.51 - $6.6 $769,888 - $1.13 Million	170,707 Added 34.24%	669,245 $3.31 Million
Q4 2018 Jan 31, 2019	BUY	$4.89 - $7.16 $235,160 - $344,324	48,090 Added 10.68%	498,538 $2.44 Million
Q3 2018 Nov 09, 2018	BUY	$6.89 - $7.78 $3.1 Million - $3.5 Million	450,448 New	450,448 $3.28 Million

156

147M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $331M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.